Tilray To Supply Medical Cannabis To France; Shares Gain 14%
Shares of Tilray jumped 14% in Tuesday's morning trading after the
cannabis producer said that it was selected by the French national
health agency to supply GMP (Good Manufacturing Processes)
certified medical cannabis products to patients in the country.
Tilray (TLRY) will distribute medical cannabis products through the
French National Agency for the Safety of Medicines and Health
Products (ANSM) for medical experimentation in the country. The
cannabis producer will supply medical cannabis products to French
patients in the country for the duration of the experiment, which
is scheduled to last for a period of 18 months to 24 months.